Get the lastest analysis
Know what's happening as soon as it does. Benefit from our analysts' decades of insight and market projection experience to make your next move.![fenix group cover image](https://marketplace.fenix.group/wp-content/uploads/2019/06/fenix-group-announcement.png)
Free
Posted in: Other Sep 03 | 2019FENIX to Host EASD Social Event on Monday Sept 16Access Free Blast![ADA news cover image](https://marketplace.fenix.group/wp-content/uploads/2019/06/news-ada-drugs-devices.png)
Free
Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Insulin Delivery, Other Jun 06 | 2019New Sanofi CEO; Xeris delayed: SENS approval, InPen-Dexcom; Zeal-BB; vTv; AdociaAccess Free Blast![janssen cover image](https://marketplace.fenix.group/wp-content/uploads/2018/10/LfMm2vkGSfeSWlEZBGZv.png)
Free
Posted in: SGLT2i May 22 | 2019CREDENCE Priority Review for Invokana; PDUFA Projected in Late September 2019Access Free Blast![lifescan cover image](https://marketplace.fenix.group/wp-content/uploads/2019/05/lifescan-announcement.png)
Free
Posted in: Glucose Monitoring May 21 | 2019Lifescan Enters CGM Market with New Partnership; Ty Lee Returns to LifescanAccess Free Blast![lilly and merrill cover image](https://marketplace.fenix.group/wp-content/uploads/2019/05/lilly-merrill-event.png)
Free
Posted in: Dual/triple agonist, GLP-1RA May 15 | 2019Lilly oral dual agonist comments @ BAMLAccess Free Blast![lilly cover image](https://marketplace.fenix.group/wp-content/uploads/2018/10/VI9cc1ReuiKG2JKPvWEA.png)
Free
Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Dual/triple agonist, GLP-1RA, Glucagon, Glucose Monitoring, Insulin Delivery, SGLT2i Apr 30 | 2019REWIND Filed; Empa T1DM, Nasal Glucagon Delayed; Lilly Q1 '19 Earnings UpdateAccess Free Blast![](https://marketplace.fenix.group/wp-content/uploads/2019/06/amarin-graphic-smooth.jpg)
Free
Posted in: Other Nov 14 | 2018Amarin’s REDUCE-IT: Winners, Losers, and Suitors AnalysisAccess Free Blast